Four Additional Innovators Receive Funding from Saving Lives at Birth

December 21, 2016

Washington, DC– The  Saving Lives at Birth: A Grand Challenge for Development partners are announcing nearly $3,500,000 in additional support for four groundbreaking health innovations, including two transition-to-scale award nominations, that aim to improve and sustain maternal and neonatal health in Kenya and that could be adapted to other low-resource settings.

These additional award nominees for Saving Lives at Birth’s Sixth Call for Innovations include:

One (1) seed award:

  • PATH (USA):launching the investigation of a needle-free method of administering the antibiotic gentamicin via the rectal route to treat neonatal sepsis.

One (1) validation award:

  • PATH (USA):validating a low-cost protein-to-creatinine (PrCr) strip test to improve diagnosis of pre-eclampsia within the routine antenatal period of maternal health care. 

Two (2) Transition-to-Scale award nominees:

  • JSI (USA):  replicating the cStock approach, a mobile health logistics management information and resupply system, to make health commodity supply chains more efficient at the community level in Kenya.
  • Massachusetts General Hospital (USA):building capacity of Kenyan healthcare providers to use ketamine anesthesia for emergency C-sections when no anesthetist is available.

The additional award nominees will join 12 other awards that were announced in July at the sixth annual DevelopmentXChange. Together, they add to the growing community of Saving Life at Birth innovators who are transforming the global health landscape by making life-saving technologies, approaches and services accessible to women and newborns in some of the poorest and hardest-to-reach areas of the world. 


About Saving Lives at Birth

The Saving Lives at Birth partnership, launched in 2011, includes the U.S. Agency for International Development (USAID), the Government of Norway, the Bill & Melinda Gates Foundation, Grand Challenges Canada (funded by the Government of Canada), the U.K’s Department for International Development (DFID) and the Korea International Cooperation Agency (KOICA). It is a global call for groundbreaking, scalable solutions to end infant and maternal mortality around the time of birth.

Saving Lives at Birth aims to address the 303,000 maternal deaths, 2.7 million neonatal deaths, and 2.6 million stillbirths that occur each year around the world. To date, successful Saving Lives at Birth innovations are already beginning to scale supporting over 1.5 million women and newborns and saving nearly 10,000 lives.

To learn more about Saving Lives at Birth and its six rounds of innovators working in maternal and newborn health, go  The program also recently released its seventh call for innovations.

Download a PDF copy of this Press Release